Sella, A <br/><br/>
Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancer.  [electronic resource] 

 -  Cancer biotherapy  1995 
 - 225-35 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1062-8401 
<br/><br/><label>Standard No.: </label>10.1089/cbr.1995.10.225  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibiotics, Antineoplastic--therapeutic use<br/>Dactinomycin--therapeutic use<br/>Drug Therapy, Combination<br/>Enzyme-Linked Immunosorbent Assay<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Prostatic Neoplasms--drug therapy<br/>Receptors, Tumor Necrosis Factor--drug effects<br/>Tumor Cells, Cultured<br/>Tumor Necrosis Factor-alpha--metabolism